TNF and myeloid sarcoma: PBMCs from healthy subjects (Figure 5A) and RR-MS patients (Figure 5B) were pre-treated (30 min) with baclofen (10, 30, and 100 μM) prior to LPS exposure (24 h) and TNF-α expression assessed.